Jade Therapeutics Company Profile
Jade Therapeutics, founded by Drs. Barbara Wirostko and MaryJane Rafii, is a privately held company headquartered in Salt Lake City, Utah, that develops locally administered, sustained-release formulations of (mostly) already-approved drugs for use in poorly served ophthalmic indications. This approach could enable improved therapeutic outcomes along with increased patient compliance to therapy, decreased frequency of administration and office visits, and avoidance of subsequent surgeries – ultimately resulting in better visual function with enhanced quality of life. Jade believes that its use of proprietary administration formulations of drugs that have already received regulatory approval may significantly decrease development risks and shorten the clinical trial and regulatory approval process. Jade’s lead programs focus on delivering (1) recombinant human growth hormone to help address persistent corneal epithelial defects, and (2) antibiotics to treat bacterial keratitis and corneal ulcers (utilizing funding from a recently awarded National Science Foundation SBIR grant).
News from Jade Therapeutics:
Jade Therapeutics Awarded $725K Phase II SBIR Grant from the National Science Foundation
Funding will support work on sustained delivery of antibiotics to the eye SALT LAKE CITY, Dec. 1, 2014 /PRNewswire/ — Jade Therapeutics, Inc., announced today that the company has been awarded a $725,000 Phase II Small Business Innovation Research (SBIR) grant from the National Science Foundation entitled, "Biodegradable Polymer Film for Sustained Delivery of Antibiotics […]
Jade Therapeutics Names Ophthalmology Pioneer Randall Olson, M.D., to its Board of Directors
Leading force behind the John A. Moran Eye Center SALT LAKE CITY, Nov. 20, 2014 /PRNewswire/ — Jade Therapeutics, Inc., announced today the election of Randall Olson, M.D., Chief Executive Officer and Chair of the Department of Ophthalmology and Visual Sciences of the John A. Moran Eye Center at the University of Utah School of Medicine, […]
Jade Therapeutics Elects Veteran Life Science Entrepreneur Dinesh Patel, Ph.D., to its Board of Directors
SALT LAKE CITY, Nov. 13, 2013 /PRNewswire/ — Jade Therapeutics, Inc. announced today the election of veteran life science entrepreneur and venture capitalist Dinesh Patel, Ph.D., to the Company's Board of Directors, replacing SCI Institute Associate Director Dr. Greg Jones. (Logo: http://photos.prnewswire.com/prnh/20131113/PH15704LOGO ) Dr. Patel co-founded the venture capital firm vSpring Capital (now Signal Peak Ventures) in 2000 […]
